CoChat

Autoimmune Polyendocrinopathy

Frommer, Lara, Kahaly, George J · 2019 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 97 of the 99 references it cites were found in a registry or an index.

Abstract

CONTEXT: This mini-review offers an update on the rare autoimmune polyendocrinopathy (AP) syndrome with a synopsis of recent developments. DESIGN AND RESULTS: Systematic search for studies related to pathogenesis, immunogenetics, screening, diagnosis, clinical spectrum, and epidemiology of AP. AP (orphan code ORPHA 282196) is defined as the autoimmune-induced failure of at least two glands. AP is divided into the rare juvenile type I and the adult types II to IV. The prevalence is 1:100,000 and 1:20,000 for types I and types II to IV, respectively. Whereas type I (ORPHA 3453) is a monogenetic syndrome with an autosomal recessive transmission related to mutations in the autoimmune regulator (AIRE) gene, types II to IV are genetically complex multifactorial syndromes that are strongly associated with certain alleles of HLA genes within the major histocompatibility complex located on chromosome 6, as well as the cytotoxic T lymphocyte antigen 4 and the protein tyrosine phosphatase nonreceptor type 22 genes. Addison disease is the major endocrine component of type II (ORPHA 3143), whereas the coexistence of type 1 diabetes and autoimmune thyroid disease is characteristic for type III (ORPHA 227982). Genetic screening for the AIRE gene is useful in patients with suspected type I, whereas serological screening (i.e., diabetes/adrenal antibodies) is required in patients with monoglandular autoimmunity and suspected AP. If positive, functional endocrine testing of the antibody-positive patients as well as serological screening of their first-degree relatives is recommended. CONCLUSION: Timely diagnosis, genetic counseling, and optimal long-term management of AP is best offered in specialized centers.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2019-00602

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 97 references

Research works printed but not linked: 3

  1. Claude, 1908, Insuffisance pluriglandulaire endocrinienne, J Physiol Pathol Gen, 10, 469
  2. Hansen, 2014, The polyglandular autoimmune syndrome—quality of life and family clustering [in German], Dtsch Med Wochenschr, 139, 1876
  3. Naletto, 2019, The natural history of autoimmune Addison’s disease from the detection of autoantibodies to development of the disease: a long follow-up study on 143 patients, Eur J Endocrinol, EJE-18-0313.R3

Cited by

See all 122

Metadata

Authors
Frommer, L., & Kahaly, G. J.
Affiliations
University Medical Center of the Johannes Gutenberg University Mainz (DE)
Corresponding author
Kahaly, George J
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2019-04-26
Volume
104
Issue
10
Pages
4769-4782
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W4239638973
Cited by
86
References
99
Citations by year
2026: 9 · 2025: 11 · 2024: 15 · 2023: 12 · 2022: 11 · 2021: 13 · 2020: 9 · 2019: 6
FWCI
1.50
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
autoimmune polyendocrinopathy, AIRE gene, Addison's disease, type 1 diabetes, autoimmune thyroid disease, HLA alleles, CTLA-4, PTPN, genetic screening, serological screening, monogenic autoimmunity, genetic counseling, prevalence
MeSH terms
Adult, Child, Genetic Counseling, Genetic Testing, Humans, Long-Term Care, Autoimmunity, Comorbidity, Prevalence, Polyendocrinopathies, Autoimmune

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autoimmune Polyendocrinopathy. https://app.cochat.ai/papers/10.1210/jc.2019-00602
The paper
Frommer, L., & Kahaly, G. J. (2019). Autoimmune Polyendocrinopathy. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2019-00602

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.